Idiopathic chronic dysautonomia: When should the diagnosis be made?;Dysautonomie chronique idiopathique: Quand porter le diagnostic?

Revue Neurologique

Volumn 162, Issue 8-9, 2006, Pages 869-871

  Laksiri, N ^a   Azulay, J P ^a   Uzenot, D ^a   Pouget, J ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

Autoimmune autonomic neuropathy; Autonomic neuropathy; Neurogenic orthostatic hypotension; Pandysautonomia; Pure autonomic failure

Indexed keywords

ADULT; ANHIDROSIS; ARTICLE; CARDIOVASCULAR RESPONSE; CASE REPORT; CEREBELLUM DISEASE; CLINICAL FEATURE; DIARRHEA; DYSAUTONOMIA; EXTRAPYRAMIDAL SYNDROME; FEMALE; HORNER SYNDROME; HUMAN; NEUROPATHY; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PHYSICAL EXAMINATION; PYRAMIDAL SIGN; SHY DRAGER SYNDROME; SYNCOPE;

EID: 33748514120     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(06)75093-7     Document Type: Article

References (17)

1. BUSSE A, SANCHEZ MA, MONTERROSO V, ALVARADO MV, LEON P. (2004). A severe form of amyloidotic polyneuropathy in a Costa Rican family with a rare transthyretin mutation (Glu54Lys). Am J Med Genet A, 128: 190-194.
2. CHAN KH, VERNINO S, LENNON VA. (2001). ANNA-3 anti-neuronal nuclear antibody: marker of lung cancer-related autoimmunity. Ann Neurol, 50: 301-311.
3. FAGIUS J. (1993). Syndromes of autonomic overactivity: clinical presentation, assessment, and management. In: Clinical autonomic disorders: evaluation and management. Low PA, editor. Boston: Little, Brown: pp. 197-208.
4. GOLDSTEIN DS, POLINSKY RJ, GARTY M et al. (1989). Patterns of plasma levels of catechols in neurogenic orthostatic hypotension. Ann Neurol, 26: 558-563.
5. HANCOCK BW, NAYSMITH A. (1975). Vincristine-induced autonomic neuropathy. Br Med J, 3: 207.
6. KAUFMANN H, NAHM K, PUROHIT D, WOLFE D. (2004). Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology, 63: 1093-1095.
7. KLEIN C, VERNINO S, LENNON V et al. (2003). The Spectrum of Autoimmune Autonomic Neuropathies. Ann Neurol, 53: 752-758.
8. LOW PA, VERNINO S, SUAREZ G. (2003). Autonomic dysfunction in peripheral nerve disease. Muscle Nerve, 27: 646-661.
9. LOW PA, BENRUD-LARSON LM, SLETTEN DM et al. (2004). Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care, 27: 2942-2947.
10. MATHIAS CJ. (1997).Autonomic disorders and their recognition. N Engl J Med, 10: 721-724.
11. MATHIAS CJ. (2000). Disorders of the Autonomic Nervous System. In Bradley WJ, Danoff RB, Fenichel GM, Marsden CD (eds.) Neurology in clinical practice Third edition. Butterworth- Heinemann edition. Oxford. Vol. 1, pp. 2131-2165.
12. th ed). Oxford: Oxford University Press.
13. MCLEOD JG. (1992). Invited review: autonomic dysfunction in peripheral nerve disease. Muscle Nerve, 15: 3-13.
14. NAVARRO X, MIRALLES R, ESPADALER JM, RUBIES-PRAT J. (1991). Troubles autonomes cardiovasculaires et sudoromoteurs dans l'alcoolisme chronique. In: Le système nerveux autonome. Acquisitions récentes. Expansion Scientifique Française. Paris, pp. 181-185.
15. ROSENFELD CS, BRODER LE. (1984). Cisplatin-induced autonomic neuropathy. Cancer Treat Rep, 68 : 659-660.
16. VERNINO S, ADAMSKI J, KRYZER TJ, FEALEY RD, LENNON VA. (1998). Neuronal nicotinic Ach receptor antibody in sub acute autonomic neuropathy and cancer-related syndromes. Neurology, 50: 1806-1813.
17. VERNINO S, LOW PA, FEALEY R, STEWART J, FARRUGIA G, LENNON V. (2000). Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med, 12: 847-855.